Heron Therapeutics | Ativo Circulante

Current Assets Alterar Data
ALKERMES USD 1.46B 67.43M 2023-09
Alnylam Pharmaceuticals USD 2.98B 2.76M 2023-12
Amarin USD 717.51M 11.02M 2023-09
ANI Pharmaceuticals USD 519.82M 22.6M 2023-12
Arrowhead Research USD 237.9M 181.62M 2023-12
Eisai JPY 659.27B 19.2B 2023-09
GlaxoSmithKline GBP 21.24B 1.89B 2023-09
Insmed USD 929.06M 2.49M 2023-12
Ligand Pharmaceuticals USD 237.43M 16.56M 2023-12
Merck USD 31.95B 1.98B 2023-09
Neurocrine Biosciences USD 1.65B 153.3M 2023-09
Pacira USD 509.99M 62.74M 2023-12
Regeneron Pharmaceuticals USD 24.49B 5.85B 2023-12
Roche Holding CHF 30.98B 2.84B 2023-06
Ultragenyx Pharmaceutical USD 599.19M 102.95M 2023-09
Veracyte USD 285.62M 14.46M 2023-12
Vertex Pharmaceuticals USD 14.7B 822.9M 2023-09



Heron Therapeutics Ativo Circulante - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Apr 2024.